Karin Wingstrand

Board Member

Born in 1957. MSc in Pharmacy, University of Uppsala Karin comes with extensive knowledge of R&D in the international life science sector. She has held positions such as Global head of Clinical Development and Global head of Pharmaceutical and Analytical R&D at AstraZeneca. She is a senior advisor to pharmaceutical and med tech organizations and has broad experience as board member from several life science companies as well as an ‘angel-investments’ company. Board member since 2019

Shares in Integrum, own and party holders:

Stockoption 2019/2022: 20 000
Independent in relation to the Company and company management as well as independent in relation to the Company larger shareholders.